EndoShunt had the incredible honor of joining the #Beahrs Surgical Innovation Summit hosted by Mayo Clinic's Department of Surgery! Being surrounded by some of the brightest minds in clinical innovation was nothing short of inspiring. The connections and insights we gained are already fueling our drive to push EndoShunt closer to making a real difference for patients and clinicians. We are more energized than ever to innovate, collaborate, and redefine what's possible in the future of abdominal hemorrhage control! #Innovation #healthcare #BearhsSummit #MayoClinic #MedTech #MedicalDevice #SurgicalDevice #GiftofTIME #GiftofLIFE
EndoShunt Medical
医疗设备制造业
Chicago,Illinois 684 位关注者
EndoShunt is the gift of TIME, for trauma surgeons, and the gift of LIFE, for trauma patients.
关于我们
EndoShunt is an innovative medical device for targeted hemorrhage control in emergency situations.
- 所属行业
- 医疗设备制造业
- 规模
- 2-10 人
- 总部
- Chicago,Illinois
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Trauma、Hemorrhage control、Reperfusion injury's、Emergency medicine和Intuitive user interface
地点
EndoShunt Medical员工
-
Haven Allen
Chief Executive Officer at mHUB
-
Tyler Zanon
CEO | R&D Project Manager | New Product Design and Innovation I PMP
-
Michael Finn-Henry
Harvard PhD Candidate, Co-Founder at EndoShunt Medical, Former World Cup Speed Climber
-
Rohan Nigam
Clinical Research Coordinator at Vanderbilt University Medical Center
动态
-
We’re incredibly proud of our co-founder, Michael Finn-Henry, who is running the 2025 Boston Marathon with The Gillian Reny Stepping Strong Center for Trauma Innovation an organization supporting vital trauma medicine research. At EndoShunt, we are deeply committed to advancing trauma care and supporting the survivor community in every way we can. Michael’s participation in this marathon is just one example of how we strive to make a difference in the lives of trauma patients. Join us in supporting this important cause—please share and donate to help push the boundaries of trauma medicine and improve survival outcomes. #BostonMarathon #TraumaResearch #EndoShunt #SteppingStrong #MedicalInnovation
Now, more than ever, private funding for medical research is critical! I’m running the 2025 Boston Marathon with the Stepping Strong Marathon Team to raise funds supporting research for survivors of traumatic injury. Our goal is to ensure these young, healthy patients can enjoy many more years of a healthy life. Join me in this important quest by sharing our story and donating to support trauma research. Together, we can push new frontiers in trauma medicine and help patients live longer, healthier lives. Please share and donate—every contribution counts! #BostonMarathon #TraumaResearch #EndoShunt #SteppingStrong #MedicalInnovation The Gillian Reny Stepping Strong Center for Trauma Innovation
-
Startups are always in learning mode—constantly at the cutting-edge of our technology, partnership, team, customers, and the market landscape. At EndoShunt, we are fortunate to have close relationships with knowledgeable end-users informing hands-on customer discovery, along with fact-based decision-making at the core of our process. The NSF's iCorps program provided our team with a valuable framework to accelerate customer discovery and de-risk our product-market fit. We are grateful to have the support and guidance of the fantastic team at the Mid-South Hub throughout this journey. Any startup would be lucky to have such an amazing resource!
In the fast-evolving landscape of medical technology, EndoShunt Medical stands out as a beacon of innovation. This startup, driven by the relentless pursuit of excellence and the need to address critical gaps in trauma surgery, made significant strides through its participation in the National I-Corps program. Michael Finn-Henry, co-founder of Endoshunt, shares his journey, the challenges they faced, and the invaluable insights gained through the program that ultimately led them to pivot in crucial ways.?Click here to read more: https://lnkd.in/exjyg4yB
-
Today, we remember and honor the brave men and women who made the ultimate sacrifice for our freedom. We express our deepest gratitude to their families for their immense sacrifice and support. #MemorialDay #HonorandRemember
-
EndoShunt is delighted to be recognized as Harvard’s most impactful life sciences innovation in the Harvard President's Innovation Challenge. We are grateful to our supporters at Harvard University, including the Harvard Innovation Labs, Harvard John A. Paulson School of Engineering and Applied Sciences, and Harvard Business School. Special thanks to Alan Garber and the Bertarelli Foundation for their invaluable contributions to the PIC awards. #impact #iLab #HarvardPIC #TheGiftOfTime #StopTheBleed
-
We're thrilled to announce that EndoShunt is a finalist in the Harvard President's Innovation Challenge! This is a huge milestone for us, and we're excited to be recognized for our truely ground breaking innovation for controlling abdominal bleeding in trauma surgery. We invite everyone to join us on May 1st to see the pitches and celebrate as we work to transform patient care. Don’t forget to RSVP: https://bit.ly/3Q4i5Nq See you there! #HarvardInnovationLabs #PIC2024 #EndoShuntMedical #MedTech #InnovationChallenge
A huge congratulations to the finalists in the President’s Innovation Challenge Student Health + Life Sciences Track. These 2024 ventures are driving impact by introducing groundbreaking solutions in cell therapy, trauma surgery, drug safety, and neurological treatments, significantly advancing medical practice and patient care. Cellforma : Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs. EndoShunt Medical : Controlling abdominal bleeding in trauma surgery with an innovative medical device. MabLab : Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs. Modulate Bio : Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety. neumind : Digitizing neurorehabilitation for enhanced patient access, seamless caregiver involvement, and improved clinician overview. #PIC2024 RSVP to attend the awards ceremony on May 1 online or in-person at Klarman Hall (in-person is sold out, but you can hop on the waitlist!) https://bit.ly/3Q4i5Nq
-
?? Exciting news from EndoShunt Medical Inc.! ?? We're thrilled to announce that we advancing to the final day of pitching in the prestigious 2024 Rice Business Plan Competition! ?? As we gear up to showcase our groundbreaking endovascular device, designed to revolutionize trauma surgery, we're eager to connect with fellow innovators, investors, and industry leaders. ?? Follow along with our journey as we strive to make a meaningful impact in the world of medical technology! ?? #RBPC2024 #EndoShuntMedical #Innovation #MedicalTechnology
Student startups at the Rice Business Plan Competition have officially completed their first Round pitches. As we tally the scores to see who heads on to the semi-final, startups are getting feedback from judges: active investors, successful entrepreneurs and supportive members of the entrepreneurial community. These student entrepreneurs are building the foundation for truly remarkable companies—all while pursuing university degrees from across the country and globe. Join us in giving them a round of applause for their hard work so far. ?? Learn more about the companies. A full directory with info on each is available to view: https://lnkd.in/gY3q2Sm9 ?? Cheer them on in the finals, during the livestream, and follow their progress in the competition: https://lnkd.in/g3vpeaQ7
2024 RBPC Startups
rbpc.rice.edu
-
EndoShunt is thrilled to share that we were awarded second place in the esteemed UMassM2D2 #200KChallenge. It was an honor to share our story with such incredible judges, attendees, and fellow organizations - all working to make substantially impactful differences in #medtech and #healthcare. Thank you to UMassM2D2, Asahi Intecc USA, Inc., Mintz, Prime Path Medtech?, and Bene Studio for your belief in and support of our organization! #innovation #healthtech #Pitchcompetition #medicaldevice #seedround #fundraise #giftofTIME #giftofLIFE
Thank you to the hundreds of #medtech #entrepreneurs, #LifeSciences experts, investors, sponsors and community members who joined us last night for the BIGGEST #200KChallenge in years. For the first time in $200K Challenge history, we had a SOLD OUT event. The iHub could barely contain the innovative ideas, energy and attendees who spent their evening in Lowell. A massive thank you to the sponsors who help make the $200K Challenge possible, and provide resources and funding to the finalists. Your ongoing support continues to help us drive healthcare innovation around the world. And finally, congratulations to this year's Challenge winners! Your stellar pitch presentations wowed the judges, leading to one of the closest competitions we've seen. Your overall determination to solve healthcare challenges is inspiring. We can't wait to where you are headed next! The 2024 Challenge winners: ?? First Place:?Relavo, for their?disinfecting connection device that reduces infection risk associated with dialysis. ?? Second Place:?EndoShunt Medical, for their?temporary, minimally invasive hemorrhage control device that creates a size-adjustable channel inside the IVC or aorta. ?? Third Place:?Neuraura, for their?device that uses low-frequency electrostimulation to treat symptoms associated with polycystic ovarian syndrome (PCOS). ?? M2D2 $25K Cash Award:?Nucyrna Therapeutics, for their?oligonucleotide platform enabling next-gen RNA-targeting therapeutics for CNS disorders. ?? Massachusetts Life Sciences Center $50K Award:?Lilypad Health,?for their?menstrual pad add-on that screens for diseases high-risk HPV, HIV, and other STDs. These Finalists won a total of?$200K in in-kind support?from our event sponsors: ?? AIRS Medical:?Awards from Inertia Product Development and bene : studio ?? Armor Medical Inc: Award from MPR Associates, Inc. ?? Calliope Biophysics:?Award from Johnson & Johnson MedTech ?? Cellens Inc: Award from bene : studio ?? EndoShunt Medical:?Awards from?Asahi Intecc USA, Inc., Mintz, Prime Path Medtech?, and bene : studio. ?? GenAssist: Award from Hologic, Inc. ?? Lilypad Health:?Award from?Argenta Advisors, Inc. ?? Neuaura:?Award from?PrimePath. ?? Nucyrna Therapeutics:?Award from Amgen. ?? Relavo Medical:?Award from Prime Path Medtech. Congratulations again to these hardworking #Startups and entrepreneurs!
-
EndoShunt is extremely honored to be selected as a finalist for University of Massachusetts Lowell's upcoming #M2D2 Pitch Competition - an event whose goal is "identifying and rewarding disruptive companies in the medical technology & biotechnology industries"! During this event, EndoShunt will have the opportunity to share our story with an impressive network of investors, industry leaders, and medical device development experts! If you're on the East Coast, we'd welcome your attendance and would gladly connect while our team is in the area. https://lnkd.in/gPMEwgtf #startup #medicaldevice #pitchcompetition #seedround #fundraising #medtech #traumasurgery #angelinvesting #venturecapital #giftoftime #giftoflife
M2D2 2024 $200K Challenge Pitch-Off & Awards Announcement
eventbrite.com